KINDAL REYNOLDS: Open Payments
NPI 1477321917 · GENTRY, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$377 in 20 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $584 · 2025 $377
Food & beverage: $377
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $149 |
| Novo Nordisk Inc | 5 | $83 |
| Lilly USA, LLC | 3 | $51 |
| Phathom Pharmaceuticals, Inc. | 2 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| Amgen Inc. | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Dexcom, Inc. | 1 | $16 |
Products named: AIRSUPRA, Ozempic, JARDIANCE, FARXIGA, MOUNJARO, VOQUEZNA, EVENITY, Rybelsus.
Industry payments across AR — which companies pay providers there.
